Michaela Levin

Corporate Officer/Principal at ACRIVON THERAPEUTICS, INC.

Net worth: 61 500 $ as of 29/09/2026

Health Technology

Consumer Services

Profile

Michaela Levin is currently Chief Business Officer at Acrivon Therapeutics, Inc. Formerly, Dr. Levin was Vice President-Business Development at Recursion Pharmaceuticals, Inc. Dr. Levin earned a doctorate from the University of Virginia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ACRIVON THERAPEUTICS, INC. 0.07%	30/08/2026	30,000 ( 0.07% )	61 500 $	29/09/2026

Michaela Levin active positions

Companies	Position	Start
ACRIVON THERAPEUTICS, INC.	Corporate Officer/Principal	30/08/2026

All active positions of Michaela Levin

Former positions of Michaela Levin

Companies	Position	End
RECURSION PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

See the detail of Michaela Levin's experience

Education of Michaela Levin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michaela Levin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Recursion Pharmaceuticals, Inc. Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery	Health Technology
University of Virginia University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Acrivon Therapeutics, Inc. Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines	Health Technology